Predicting the 2030 Genomic Landscape: A Decade of CRISPR Innovation
The trajectory of genomic medicine is pointing toward a future where "one-and-done" cures are the standard rather than the exception. As we project the next ten years of development, the focus is shifting toward in-vivo editing—delivering CRISPR components directly into the human body. This would eliminate the need for expensive and complex ex-vivo procedures where cells are removed,...
0 Comments 0 Shares 50 Views 0 Reviews
MakeMyFriends https://makemyfriends.com